Arbios Systems, Inc. Stock Other OTC

ARBI

US03875V2060

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Managers and Directors: Arbios Systems, Inc.

Manager	Title	Age	Since
Thomas J. Fagan CEO	Chief Executive Officer	-	-

Director	Title	Age	Since
Thomas J. Fagan CHM	Chairman	-	-

More insiders

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARBIOS SYSTEMS, INC.	-93.90%	-.--%	-	-	50
ABBOTT LABORATORIES	+0.96%	+1.07%	-17.58%	+3.37%	187B
MEDTRONIC PLC	+1.97%	+2.33%	-4.36%	+6.71%	112B
CENCORA, INC.	+1.04%	+4.76%	+11.13%	+72.72%	61.15B
HOYA CORPORATION	+2.38%	+6.38%	+35.52%	+59.33%	54.39B
BECTON, DICKINSON AND COMPANY	+0.92%	+4.47%	-7.63%	-35.86%	48.17B
DEXCOM, INC.	+3.79%	+0.02%	+12.18%	-22.90%	31.98B
MEDLINE INC.	-3.89%	-16.58%	-	-	30.91B
WEST PHARMACEUTICAL SERVICES, INC.	+0.86%	+2.13%	+47.85%	-11.22%	24.92B
STERIS PLC	-0.19%	+1.51%	-2.26%	+3.93%	23.15B
Average	-8.84%	+1.86%	+9.36%	+9.51%	63.64B
Weighted average by Cap.	+0.94%	+2.17%	+0.02%	+11.82%

See all sector performances

Arbios Systems, Inc. (Arbios) is a medical device and cell-therapy company focused on the development of products for the treatment of liver failure. The Company's lead product candidates under development consist of a extracorporeal blood purification therapy called the SEPET Liver Assist Device and an extracorporeal, bioartificial liver therapy referred to as the HepatAssist Cell-Based Liver Support System that incorporate porcine pig liver cells. In October 2008, Arbios announced that it has sold all its rights and interest in its bioartificial liver system, HepatAssist, to HepaLife Technologies, Inc. On January 9, 2009, Arbios announced that it filed for protection under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company